137 related articles for article (PubMed ID: 18219411)
21. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.
Svízenská I; Dubový P; Sulcová A
Pharmacol Biochem Behav; 2008 Oct; 90(4):501-11. PubMed ID: 18584858
[TBL] [Abstract][Full Text] [Related]
22. Discovery of novel Tetrahydrobenzo[b]thiophene and pyrrole based scaffolds as potent and selective CB2 receptor ligands: The structural elements controlling binding affinity, selectivity and functionality.
Osman NA; Ligresti A; Klein CD; Allarà M; Rabbito A; Di Marzo V; Abouzid KA; Abadi AH
Eur J Med Chem; 2016 Oct; 122():619-634. PubMed ID: 27448919
[TBL] [Abstract][Full Text] [Related]
23. Identification of novel cannabinoid CB1 receptor antagonists by using virtual screening with a pharmacophore model.
Wang H; Duffy RA; Boykow GC; Chackalamannil S; Madison VS
J Med Chem; 2008 Apr; 51(8):2439-46. PubMed ID: 18363352
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, cannabinoid receptor affinity, and molecular modeling studies of substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides.
Silvestri R; Cascio MG; La Regina G; Piscitelli F; Lavecchia A; Brizzi A; Pasquini S; Botta M; Novellino E; Di Marzo V; Corelli F
J Med Chem; 2008 Mar; 51(6):1560-76. PubMed ID: 18293908
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.
Cianchi F; Papucci L; Schiavone N; Lulli M; Magnelli L; Vinci MC; Messerini L; Manera C; Ronconi E; Romagnani P; Donnini M; Perigli G; Trallori G; Tanganelli E; Capaccioli S; Masini E
Clin Cancer Res; 2008 Dec; 14(23):7691-700. PubMed ID: 19047095
[TBL] [Abstract][Full Text] [Related]
26. 7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as selective CB(2) cannabinoid receptor ligands: structural investigations around a novel class of full agonists.
Baraldi PG; Saponaro G; Moorman AR; Romagnoli R; Preti D; Baraldi S; Ruggiero E; Varani K; Targa M; Vincenzi F; Borea PA; Aghazadeh Tabrizi M
J Med Chem; 2012 Jul; 55(14):6608-23. PubMed ID: 22738271
[TBL] [Abstract][Full Text] [Related]
27. Novel pyrazole-3-carboxamide derivatives as cannabinoid-1 (CB1) antagonists: journey from non-polar to polar amides.
Sasmal PK; Reddy DS; Talwar R; Venkatesham B; Balasubrahmanyam D; Kannan M; Srinivas P; Kyasa SK; Devi BN; Jadhav VP; Khan SK; Mohan P; Chaudhury H; Bhuniya D; Iqbal J; Chakrabarti R
Bioorg Med Chem Lett; 2011 Jan; 21(1):562-8. PubMed ID: 21075633
[TBL] [Abstract][Full Text] [Related]
28. Novel benzimidazole derivatives as selective CB2 agonists.
Pagé D; Balaux E; Boisvert L; Liu Z; Milburn C; Tremblay M; Wei Z; Woo S; Luo X; Cheng YX; Yang H; Srivastava S; Zhou F; Brown W; Tomaszewski M; Walpole C; Hodzic L; St-Onge S; Godbout C; Salois D; Payza K
Bioorg Med Chem Lett; 2008 Jul; 18(13):3695-700. PubMed ID: 18522867
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and SAR of 1,4,5,6-tetrahydropyridazines as potent cannabinoid CB1 receptor antagonists.
Lange JH; den Hartog AP; van der Neut MA; van Vliet BJ; Kruse CG
Bioorg Med Chem Lett; 2009 Oct; 19(19):5675-8. PubMed ID: 19699640
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and in vitro evaluation of novel 2-oxo-1,2-dihydroquinoline CB2 receptor inverse agonists.
Raitio KH; Savinainen JR; Nevalainen T; Järvinen T; Vepsäläinen J
Chem Biol Drug Des; 2006 Dec; 68(6):334-40. PubMed ID: 17177896
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and pharmacology of 11-nor-1-methoxy-9-hydroxyhexahydrocannabinols and 11-nor-1-deoxy-9-hydroxyhexahydrocannabinols: new selective ligands for the cannabinoid CB2 receptor.
Marriott KS; Huffman JW; Wiley JL; Martin BR
Bioorg Med Chem; 2006 Apr; 14(7):2386-97. PubMed ID: 16321538
[TBL] [Abstract][Full Text] [Related]
32. Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.
Sain NM; Liang A; Kane SA; Urban MO
Neuropharmacology; 2009 Sep; 57(3):235-41. PubMed ID: 19538975
[TBL] [Abstract][Full Text] [Related]
33. Cannabilactones: a novel class of CB2 selective agonists with peripheral analgesic activity.
Khanolkar AD; Lu D; Ibrahim M; Duclos RI; Thakur GA; Malan TP; Porreca F; Veerappan V; Tian X; George C; Parrish DA; Papahatjis DP; Makriyannis A
J Med Chem; 2007 Dec; 50(26):6493-500. PubMed ID: 18038967
[TBL] [Abstract][Full Text] [Related]
34. Discovery of N-[(1S,2S)-3-(4-Chlorophenyl)-2- (3-cyanophenyl)-1-methylpropyl]-2-methyl-2- {[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonist for the treatment of obesity.
Lin LS; Lanza TJ; Jewell JP; Liu P; Shah SK; Qi H; Tong X; Wang J; Xu SS; Fong TM; Shen CP; Lao J; Xiao JC; Shearman LP; Stribling DS; Rosko K; Strack A; Marsh DJ; Feng Y; Kumar S; Samuel K; Yin W; Van der Ploeg LH; Goulet MT; Hagmann WK
J Med Chem; 2006 Dec; 49(26):7584-7. PubMed ID: 17181138
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain management.
Nelson DW; Frost JM; Tietje KR; Florjancic AS; Ryther K; Carroll WA; Dart MJ; Daza AV; Hooker BA; Grayson GK; Fan Y; Garrison TR; El-Kouhen OF; Yao B; Pai M; Chandran P; Zhu C; Hsieh GC; Meyer MD
Bioorg Med Chem Lett; 2012 Apr; 22(7):2604-8. PubMed ID: 22370265
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in CB1 cannabinoid receptor antagonists.
Lange JH; Kruse CG
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):498-506. PubMed ID: 15338959
[TBL] [Abstract][Full Text] [Related]
37. Substituted pyrimidines as cannabinoid CB1 receptor ligands.
Kim MJ; Kim JY; Seo HJ; Lee J; Lee SH; Kim MS; Kang J; Kim J; Lee J
Bioorg Med Chem Lett; 2009 Aug; 19(16):4692-7. PubMed ID: 19596576
[TBL] [Abstract][Full Text] [Related]
38. Exploring the substituent effects on a novel series of C1'-dimethyl-aryl Delta8-tetrahydrocannabinol analogs.
Krishnamurthy M; Gurley S; Moore BM
Bioorg Med Chem; 2008 Jul; 16(13):6489-500. PubMed ID: 18524604
[TBL] [Abstract][Full Text] [Related]
39. Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazole: a versatile architecture for CB2 selective ligands.
Pinna G; Loriga G; Lazzari P; Ruiu S; Falzoi M; Frau S; Pau A; Murineddu G; Asproni B; Pinna GA
Eur J Med Chem; 2014 Jul; 82():281-92. PubMed ID: 24922543
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor.
Moloney GP; Angus JA; Robertson AD; Stoermer MJ; Robinson M; Wright CE; McRae K; Christopoulos A
Eur J Med Chem; 2008 Mar; 43(3):513-39. PubMed ID: 17582659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
